What is Dechra Pharmaceuticals Price-to-Free-Cash-Flow?
As of today (2024-04-29), Dechra Pharmaceuticals's share price is £38.66.
Dechra Pharmaceuticals's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.29. Hence, Dechra Pharmaceuticals's Price-to-Free-Cash-Flow Ratio for today is 131.95.
The historical rank and industry rank for Dechra Pharmaceuticals's Price-to-Free-Cash-Flow or its related term are showing as below:
LSE:DPH'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 20.73 Med: 47.4 Max: 224.89
Current: 131.95
During the past 13 years, Dechra Pharmaceuticals's highest Price-to-Free-Cash-Flow Ratio was 224.89. The lowest was 20.73. And the median was 47.40.
LSE:DPH's Price-to-Free-Cash-Flow is not ranked
in the Drug Manufacturers industry.
Industry Median: 22.08
vs LSE:DPH: 131.95
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Dechra Pharmaceuticals was -29.80% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -19.20% per year.
During the past 13 years, Dechra Pharmaceuticals's highest 3-Year average Free Cash Flow per Share Growth Rate was 147.80% per year. The lowest was -35.50% per year. And the median was 8.00% per year.
Dechra Pharmaceuticals Price-to-Free-Cash-Flow Historical Data
The historical data trend for Dechra Pharmaceuticals's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dechra Pharmaceuticals's Price-to-Free-Cash-Flow
For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dechra Pharmaceuticals's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Dechra Pharmaceuticals's Price-to-Free-Cash-Flow falls into.
Dechra Pharmaceuticals's Share Price of today is £38.66.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dechra Pharmaceuticals's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Dechra Pharmaceuticals Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Dechra Pharmaceuticals's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Dechra Pharmaceuticals (LSE:DPH) Business Description
Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:DPH has been successfully added to your 